Brain-Disabling Treatments in Psychiatry: Drugs, Electroshock, and the Psychopharmaceutical Complex - Image 1

£52.48

Springer Publishing Company Brain-Disabling Treatments in Psychiatry: Drugs, Electroshock, and the Psychopharmaceutical Complex

Name: Brain-Disabling Treatments in Psychiatry: Drugs, Electroshock, and the Psychopharmaceutical Complex
Brand: Springer Publishing Company
Price: 52.48 GBP
Availability: InStock

Drugs

This is the usual price. Wait for it to drop, or tell us your number.

£52 today · usual range £0–£0 · best ever £37

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey

↓ Forecast
where the price is heading next

↓ Statistics
all-time high & low, recent range

↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 594 days • 594 data points (No recent data available)

Historical

Generating forecast...

Price Distribution

Price distribution over 594 days • 4 price ranges

Days at Price

Current Price

Price Analysis

Most common range: £57-62 (353 days, 59.4%)

Price range: £37 - £62

Price levels: 4 price ranges over 594 days

Description

From the author of Toxic Psychiatry and Talking Back to Prozac: Peter Breggin is the conscience of American psychiatry. Once more he updates us on the real evidence with respect to the safety and effectiveness of specific psychiatric medications and ECT. This information is needed by all mental health professionals, as well as patients and families." --Bertram Karon, Ph.D., Professor of Psychology, Michigan State University, Author of The Psychotherapy of Schizophrenia "Nowhere does false medical thinking do more harm than in the modern psychiatric argument that mental illness is easily diagnosed and then cured by a side-effect free drug. Nowhere is the correct psychiatric thinking more evident than in the books by Peter Breggin. -- William Glasser, MD, psychiatrist, author of Reality Therapy In Brain Disabling Treatments in Psychiatry, renowned psychiatrist Peter R. Breggin, M.D., presents startling scientific research on the dangerous behavioral abnormalities and brain dysfunctions produced by the most widely used and newest psychiatric drugs such as Prozac, Paxil, Zoloft, Cymbalta, Effexor, Xanax, Ativan, Ritalin, Adderall, Concerta, Strattera, Risperdal, Zyprexa, Geodon, Abilify, lithium and Depakote. Many of Breggin's earlier findings have improved clinical practice, led to legal victories against drug companies, and resulted in FDA-mandated changes in what the manufacturers must admit about their drugs. Yet reliance on these drugs has continued to escalate in the last decade, and drug company interests have overwhelmed psychiatric practice. This greatly expanded second edition, supported by the latest evidence-based research, shows that psychiatric drugs achieve their primary or essential effect by causing brain dysfunction, and that they tend to do far more harm than good. New scientific analyses in this completely updated edition include: Chapters covering every new antidepressant and stimulant drug Twenty new guidelines for how to conduct non-drug therapy A chapter describing how to safely withdraw from psychiatric drugs A discussion of "medication spellbinding," explaining how patients fail to appreciate their drug-induced mental dysfunctions Documentation of how the drug companies control research and the flow of information about psychiatric treatments

Product Specifications

Brand: Springer Publishing Company
Format: hardcover
ASIN: 082612934X
Category: Books > Subjects > Health, Family & Lifestyle > Families & Parents > Parenting > Social & Personal Issues > Drugs
Domain: Amazon UK
Release Date: 17 December 2007
Listed Since: 06 August 2007

Barcode

No barcode data available

Springer Publishing Company Brain-Disabling Treatments in Psychiatry: Drugs, Electroshock, and the Psychopharmaceutical Complex

This is the usual price. Wait for it to drop, or tell us your number.

Price History & Forecast

Price Distribution

Price Analysis

Description

Product Specifications

Barcode

Similar Products You Might Like

Principles of Psychopharmacology for Mental Health Professionals

From Placebo to Panacea: Putting Psychiatric Drugs to the Test

American Psychiatric Association Publishing Textbook of Psychopharmacology: Dsm-5 Edition

Symptom-Focused Psychiatric Drug Therapy for Managed Care: 12 (Routledge Library Editions: Psychiatry)

Mind, Brain, and Drug: An Introduction to Psychopharmacology

Handbook of Clinical Psychopharmacology for Therapists (Tenth Edition)

Psychopharmacologie essentielle. Le guide du prescripteur (3e édition française): (traduction de la 6e édition américaine)

Nurses' Clinical Consult to Psychopharmacology

Prescribing Mental Health Medication: The Practitioner's Guide

Psychopharmacologie essentielle. Bases neuroscientifiques et applications pratiques (4° Éd.)

Neuro-Psychopharmaka. Ein Therapie-Handbuch

Psychiatric Drugs in Children and Adolescents: Basic Pharmacology and Practical Applications

Drug Discovery for Psychiatric Disorders: Volume 28 (Drug Discovery Series)

Prescriber's Guide – Children and Adolescents: Stahl's Essential Psychopharmacology

Psychiatric Drug Withdrawal: A Guide for Prescribers, Therapists, Patients and their Families

Psychopharmacology

The Pharmacologic Basis of Psychotherapeutics: An Introduction for Psychologists

Meyler's Side Effects of Psychiatric Drugs

Pediatric Psychopharmacology Evidence: A Clinician's Guide

The American Psychiatric Association Publishing Textbook of Psychopharmacology, Sixth Edition: 1-2

Fundamentals of Psychopharmacology Third Edition

Handbook of Practical Psychopharmacology

Clinical Manual of Child and Adolescent Psychopharmacology

Clinical Manual of Psychopharmacology in the Medically Ill